SHILPA MEDICARE
Back to Cashflow Statement
|
SHILPA MEDICARE Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹135 Cr | ₹180 Cr | ₹105 Cr | ₹47 Cr | ₹124 Cr |
What is the latest Cash Flow from Operating Activities ratio of SHILPA MEDICARE ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹135 Cr |
Mar2023 | ₹180 Cr |
Mar2022 | ₹105 Cr |
Mar2021 | ₹47 Cr |
Mar2020 | ₹124 Cr |
How is Cash Flow from Operating Activities of SHILPA MEDICARE Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹135 Cr | -24.78 | |
Mar2023 | ₹180 Cr | 71.14 | |
Mar2022 | ₹105 Cr | 124.03 | |
Mar2021 | ₹47 Cr | -62.27 | |
Mar2020 | ₹124 Cr | - |
Compare Cash Flow from Operating Activities of peers of SHILPA MEDICARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHILPA MEDICARE | ₹6,500.3 Cr | -2.4% | -1.4% | 27.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,032.0 Cr | 0.9% | 2.2% | 23.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,252.0 Cr | 3.3% | 4.7% | 58% | Stock Analytics | |
CIPLA | ₹124,457.0 Cr | 0.5% | 2% | 11.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,425.0 Cr | -0.4% | 2.8% | 24.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,152.8 Cr | -0.8% | -0.4% | 0.8% | Stock Analytics |
SHILPA MEDICARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHILPA MEDICARE | -2.4% |
-1.4% |
27.8% |
SENSEX | 0.9% |
3% |
8.9% |
You may also like the below Video Courses